UNSPSC 51162614: Caramiphen

This classification denotes an antitussive agent with the molecular formula C18H27NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 97J7NP0XJY, chemically known as cyclopentanecarboxylic acid, 1-phenyl-, 2-(diethylamino)ethyl ester but more generally known as caramiphen, which bears US NIH Compound Identifier 6472. Caramiphen most often comes in base, ethanedisulfonate, hydrochloride, and hydrogen edisilate.

UNSPSC 51162614 Caramiphen, a Commodity code, covers pharmaceutical products that state and local governments procure through health agencies, county public health departments, and cooperative purchasing alliances to support community health and emergency response initiatives. Recent solicitations under this code show purchasing of naloxone and drug deactivation systems for community health programs, as well as generic multi-source pharmaceuticals and over-the-counter products distributed through state and local facilities. Issuing bodies include county health departments and state-administered cooperative purchasing alliances serving multiple jurisdictions. Vendors must comply with FDA requirements, current Good Manufacturing Practices, and the Drug Supply Chain Security Act, maintain specified insurance coverage including commercial general liability, and work through authorized pharmaceutical wholesalers where required.

Activity under the code centers in Florida and Minnesota, with the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issuing a Request for Proposal on January 20, 2026 to establish multiple contracts for generic pharmaceuticals and OTC products for distribution across participating state and local government facilities including Oregon, with proposals due March 26, 2026. Seminole County, Florida issued an Invitation for Bid (IFB60459723LAS) posted June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with bids due July 26, 2023. The MMCAP procurement evaluates vendors on fixed pricing (10 percent), administrative compliance (5 percent), EDI capability (5 percent), administrative fee agreement (5 percent), and price competitiveness (75 percent), with awarded vendors effective July 1, 2026 and a two-year initial contract term. The Seminole County IFB carries an initial two-year term with one-year renewal option and includes a three-month probationary termination period.